Form 4: CVS Health Corp Executive Tilak Mandadi Reports Stock Transaction
SEC Form 4 Filing
EVP and Chief Technology Officer of CVS Health, Tilak Mandadi, reports the surrender of shares for tax obligations related to vesting restricted stock units.
Summary
- On August 31, 2024, Tilak Mandadi, EVP and Chief Technology Officer of CVS Health Corp, reported a transaction involving the surrender of 13,097 common stock shares to cover withholding taxes.
- The shares were surrendered at a price of $57.24 per share.
- Following the transaction, Mandadi directly owns 40,414 shares of common stock and 49,622 restricted stock units (RSUs).
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a standard stock transaction for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 08/31/2024 | Date of stock transaction (surrender of shares). |
| 09/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.